Radiation Oncologist and head of Radiation Oncology at the University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital. My work spans clinical practice, health systems innovation, and policy, with a strong focus on improving equity and access in cancer care. Key areas of research and academic interest include:
Developing and implementing hypofractionated radiotherapy protocols (i.e. shorter radiation courses) to improve efficiency and reduce patient burden.
Using artificial intelligence and automated planning tools to support radiotherapy planning and workflow, especially in resource-constrained settings.
Exploring remote radiotherapy planning models (such as “treatment planning as a service”) to increase throughput and overcome infrastructure limitations in public academic hospitals.
Health policy, governance and the political/social determinants of cancer care, particularly in low- and middle-income countries; emphasising disruptive innovations that can democratise access to high-quality oncology services.
Radiation Oncologist and head of Radiation Oncology at the University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital. My work spans clinical practice, health systems innovation, and policy, with a strong focus on improving equity and access in cancer care. Key areas of research and academic interest include:
Developing and implementing hypofractionated radiotherapy protocols (i.e. shorter radiation courses) to improve efficiency and reduce patient burden.
Using artificial intelligence and automated planning tools to support radiotherapy planning and workflow, especially in resource-constrained settings.
Exploring remote radiotherapy planning models (such as “treatment planning as a service”) to increase throughput and overcome infrastructure limitations in public academic hospitals.
Health policy, governance and the political/social determinants of cancer care, particularly in low- and middle-income countries; emphasising disruptive innovations that can democratise access to high-quality oncology services.